Upcoming SPARK Events

Vortrag zu Tücken beim Lesen von Studienergebnissen in wissenschaftlichen Artikeln

Stefanie Ernst

…

Feierliche Zertifikatsübergabe || Festvortrag von Prof. Alastair Buchain

In den letzten Monaten…

Vortrag zu Tücken beim Lesen von Studienergebnissen in wissenschaftlichen Artikeln

Stefanie Ernst

…

Feierliche Zertifikatsübergabe || Festvortrag von Prof. Alastair Buchain

In den letzten Monaten…

Judith Weigel, vfa - die forschenden Pharma-Unternehmen

Judith Weigel, vfa - die forschenden Pharma-Unternehmen

Advanced Therapy Medicinal Products (ATMPs) are a particularly challenging medicinal product class with specific regulations. One particular challenge lies in the design of production. Moreover, the starting materials vary and regulations are tight, in terms of the quality assessment and release criteria necessary for ATMPs. New scientific insights and increased understanding of immunological and biological functions encourage development of novel ATMPs, and increase the need for understanding the regulatory requirements and the path forward from bench to bedside.

Advanced Therapy Medicinal Products (ATMPs) are a particularly challenging medicinal product class with specific regulations. One particular challenge lies in the design of production. Moreover, the starting materials vary and regulations are tight, in terms of the quality assessment and release criteria necessary for ATMPs. New scientific insights and increased understanding of immunological and biological functions encourage development of novel ATMPs, and increase the need for understanding the regulatory requirements and the path forward from bench to bedside.

Robert Nadon, Associate Professor, McGill University and Génome Québec Innovation Centre, Department of Human Genetics, McGill University, Canada

Robert Nadon, Associate Professor, McGill University and Génome Québec Innovation Centre, Department of Human Genetics, McGill University, Canada